VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ICU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ICUSeaStar Medical Holding Corporation
$3.53$14M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
ICU logo

SeaStar Medical Holding Corporation

ICU
NASDAQ · Biotechnology
$3.53
At close - Sep 23, 4:00 PM EDT - USD
Market Cap$14M
P/E-0.6x
52W High$12.50
Volume11.53K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

High Gross Margins Mask Persistent Operational Losses

SeaStar Medical is currently navigating a critical transition from research-stage development to commercial scaling, evidenced by a 68.9% year-over-year revenue growth in 2026Q1. While the company maintains a robust 90.7% gross margin, the business model remai...

GrowthExpanding
ProfitabilityNegative
ValuationReview
TechnicalsHealthy
Explore valuation models
MARKET ACTION

ICU price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

7/12 Beats

EPS beat 7 of last 12 quarters

02

Valuation risk

-103% Peers

P/E is 103% below peer median

03

Market leadership

RS 73 · Avg

Average momentum (RS Rating: 73)

04

Healthy Uptrend

Uptrend

Price > 50DMA > 200DMA

Next CatalystConfirmed earnings · Nov 12

Market performance

Price History →

Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
ICU+34.22%
S&P 500 (^GSPC)+12.39%
1-Year Return
ICU-69.57%
S&P 500 (^GSPC)+15.77%
3-Year Return
ICU-91.98%
S&P 500 (^GSPC)+78.52%
5-Year Return
ICU-99.86%
S&P 500 (^GSPC)+72.44%

Growth & profitability

Annual revenue & EPS trend
Revenue
$1M+814.1% YoY
Net income
-$12M+51.1% YoY
Free cash flow
-$14M+15.0% YoY
Operating margin
-986.6%+12229.7 pts YoY
ROIC (TTM)-
Avg ROIC 5Y-
ROE (TTM)-295.2%
Piotroski Score4 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate7/12 (58%)
Revenue Beat Rate5/12 (63%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 12, 2026
-$0.91+6.2%
vs -$0.97
$615,000+26.4%
vs $486,500
Q2 2026
May 13, 2026
-$0.90-23.3%
vs -$0.73
$495,000+13.1%
vs $437,500
Q2 2026
Mar 25, 2026
-$0.80+17.5%
vs -$0.97
$420,000+88.8%
vs $222,500
Q4 2025
Nov 13, 2025
-$1.30+13.3%
vs -$1.50
$183,000-26.8%
vs $250,000
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
GlobeNewsWire·Sep 10, 2026
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that Eric Schlorff, Chief Executive Officer of SeaStar Medical, will participate in the upcoming HC Wainwright 28th Annual Global Investment Conference being held September 14 to 16, 2026 in New York City.

GlobeNewsWire·Sep 10, 2026
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah's Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

Quoin Pharmaceuticals releases a new NETHERTON NOW video featuring Laura Wright-Sexton, MD, who first met her daughter Aminah as a patient in the ICU.

GlobeNewsWire·Aug 27, 2026
ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.

Seeking Alpha·Aug 12, 2026
SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript

SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript

Filtered for SeaStar Medical Holding CorporationMore Headlines
04

Compare before deciding

Benchmark ICU against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for SeaStar Medical Holding Corporation (ICU)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ICU logoICUSeaStar Medical Holding CorporationCurrent
$3.53$14.42M-0.60814.07%-984.6%-295.15%—
NKTR logoNKTRNektar Therapeutics
$57.66$1.91B-5.93-43.89%-287.84%-37.99%—
TPVG logoTPVGTriplePoint Venture Growth BDC Corp.
$4.92$199.75M4.0355.25%45.97%10.97%—
AKBA logoAKBAAkebia Therapeutics, Inc.
$0.93$250.18M-44.8447.46%-13.54%-93.74%—
CPRX logoCPRXCatalyst Pharmaceuticals, Inc.
$31.49$3.85B18.7419.78%37.08%23.65%—
XOMA logoXOMAXOMA Royalty Corp.
$40.17$503.77M27.5183.06%86.97%30.21%—

Compare ICU vs Peers

SeaStar Medical Holding Corporation (ICU) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NKTR

Most directly comparable listed peer for ICU.

Scale Benchmark

vs STE

Larger-name benchmark to compare ICU against a more recognizable public peer.

Peer Set

Compare Top 5

vs NKTR, TPVG, AKBA, CPRX

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

ICU SEC Filings & Documents

SeaStar Medical Holding Corporation (ICU) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 12, 2026·SEC

Material company update

Jul 1, 2026·SEC

Material company update

Jun 17, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 25, 2026·SEC

FY 2025

Mar 27, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 12, 2026·SEC

FY 2026

May 13, 2026·SEC

FY 2025

Nov 13, 2025·SEC

Get notified when ICU posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ICU Frequently Asked Questions

SeaStar Medical Holding Corporation (ICU) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is SeaStar Medical Holding Corporation's revenue?

SeaStar Medical Holding Corporation (ICU) reported $1.7M in revenue for fiscal year 2025.

How fast is SeaStar Medical Holding Corporation growing?

SeaStar Medical Holding Corporation (ICU) grew revenue by 814.1% over the past year. This is strong growth.

Is ICU profitable?

SeaStar Medical Holding Corporation (ICU) reported a net loss of $13.6M for fiscal year 2025.

Dividend & Returns
What is ICU's return on equity?

SeaStar Medical Holding Corporation (ICU) has a return on equity (ROE) of -295.2%. Negative ROE indicates the company is unprofitable.

What is SeaStar Medical Holding Corporation's free cash flow?

SeaStar Medical Holding Corporation (ICU) had negative free cash flow of $13.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in ICU back in 2020?

Total return calculator · dividends reinvested · 6+ years of data

See returns →